Development of an intradermal DNA vaccine delivery strategy to achieve single-dose immunity against respiratory syncytial virus.
about
Nucleic acid-based vaccines targeting respiratory syncytial virus: delivering the goods.Structure-based design of native-like HIV-1 envelope trimers to silence non-neutralizing epitopes and eliminate CD4 binding.A Built-In CpG Adjuvant in RSV F Protein DNA Vaccine Drives a Th1 Polarized and Enhanced Protective Immune Response.Cotton rat model for testing vaccines and antivirals against respiratory syncytial virus.DNA immunization site determines the level of gene expression and the magnitude, but not the type of the induced immune response.
P2860
Development of an intradermal DNA vaccine delivery strategy to achieve single-dose immunity against respiratory syncytial virus.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Development of an intradermal ...... t respiratory syncytial virus.
@en
type
label
Development of an intradermal ...... t respiratory syncytial virus.
@en
prefLabel
Development of an intradermal ...... t respiratory syncytial virus.
@en
P2093
P2860
P1433
P1476
Development of an intradermal ...... t respiratory syncytial virus.
@en
P2093
David B Weiner
Jay R McCoy
Karuppiah Muthumani
Katherine Schultheis
Kevin C Yim
Kimberly A Kraynyak
Laurent Humeau
Matthew P Morrow
Niranjan Y Sardesai
Trevor R F Smith
P2860
P304
P356
10.1016/J.VACCINE.2017.04.008
P407
P577
2017-04-13T00:00:00Z